Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Silver

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Israel Journal of Health Policy Research|May 16, 2018
Regulating pharmaceutical companies' financial largesseRonen Avraham, Charles Silver
Chest|January 2, 2013
Five myths of medical malpracticeDavid A Hyman, Charles Silver
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Pricing and Paying for Cancer Drugs: Policy Options for Fixing A Broken SystemDavid A Hyman, Charles Silver
Cornell Law Review|June 16, 2005
The poor state of health care quality in the U.S.: is malpractice liability part of the problem or part of the solution?David A Hyman, Charles Silver
Chest|June 5, 2013
ResponseDavid A Hyman, Charles Silver
The Journal of Legal Medicine|September 11, 2019
Why are we Being Overcharged for Pharmaceuticals? What Should We Do About It?David A Hyman, Charles Silver
BMC Genomics|May 19, 2016
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signaturesMaurizio Pellegrino, Adam Sciambi, Jamie L Yates, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Israel Journal of Health Policy Research|May 16, 2018
Regulating pharmaceutical companies' financial largesseRonen Avraham, Charles Silver
Chest|January 2, 2013
Five myths of medical malpracticeDavid A Hyman, Charles Silver
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Pricing and Paying for Cancer Drugs: Policy Options for Fixing A Broken SystemDavid A Hyman, Charles Silver
Cornell Law Review|June 16, 2005
The poor state of health care quality in the U.S.: is malpractice liability part of the problem or part of the solution?David A Hyman, Charles Silver
Chest|June 5, 2013
ResponseDavid A Hyman, Charles Silver
The Journal of Legal Medicine|September 11, 2019
Why are we Being Overcharged for Pharmaceuticals? What Should We Do About It?David A Hyman, Charles Silver
BMC Genomics|May 19, 2016
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signaturesMaurizio Pellegrino, Adam Sciambi, Jamie L Yates, et al.
Pageof 1